UBS Group’s Genesco GCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.78M Sell
82,426
-50,213
-38% -$1.76M ﹤0.01% 4781
2026
Q1
$3.85M Sell
132,639
-42,308
-24% -$1.22M ﹤0.01% 4341
2025
Q4
$4.33M Buy
174,947
+48,436
+38% +$1.39M ﹤0.01% 4171
2025
Q3
$3.67M Sell
126,511
-86,631
-41% -$2.38M ﹤0.01% 4354
2025
Q2
$4.2M Buy
213,142
+68,726
+48% +$1.44M ﹤0.01% 4053
2025
Q1
$3.07M Sell
144,416
-49,235
-25% -$1.71M ﹤0.01% 4293
2024
Q4
$8.28M Buy
193,651
+185,799
+2,366% +$6.11M ﹤0.01% 3268
2024
Q3
$213K Buy
7,852
+1,663
+27% +$46.2K ﹤0.01% 5826
2024
Q2
$160K Sell
6,189
-9,028
-59% -$236K ﹤0.01% 5820
2024
Q1
$428K Buy
15,217
+3,008
+25% +$86.8K ﹤0.01% 5327
2023
Q4
$430K Buy
12,209
+11,609
+1,935% +$357K ﹤0.01% 5218
2023
Q3
$18.5K Sell
600
-8,460
-93% -$240K ﹤0.01% 6851
2023
Q2
$227K Buy
9,060
+1,226
+16% +$35.5K ﹤0.01% 5396
2023
Q1
$289K Sell
7,834
-3,072
-28% -$135K ﹤0.01% 5116
2022
Q4
$502K Buy
10,906
+10,211
+1,469% +$463K ﹤0.01% 4702
2022
Q3
$27K Buy
695
+95
+16% +$5.08K ﹤0.01% 6998
2022
Q2
$30K Hold
600
﹤0.01% 6390
2022
Q1
$38K Sell
600
-5,064
-89% -$330K ﹤0.01% 6757
2021
Q4
$364K Buy
5,664
+5,064
+844% +$321K ﹤0.01% 5226
2021
Q3
$35K Sell
600
-118
-16% -$7.02K ﹤0.01% 6617
2021
Q2
$45K Sell
718
-22,100
-97% -$1.2M ﹤0.01% 6531
2021
Q1
$1.08M Buy
22,818
+11,380
+99% +$489K ﹤0.01% 4169
2020
Q4
$344K Sell
11,438
-6,838
-37% -$175K ﹤0.01% 4878
2020
Q3
$394K Sell
18,276
-5,093
-22% -$99.7K ﹤0.01% 4358
2020
Q2
$506K Buy
23,369
+22,451
+2,446% +$414K ﹤0.01% 4130
2020
Q1
$12K Sell
918
-13,483
-94% -$455K ﹤0.01% 6818
2019
Q4
$691K Buy
14,401
+12,547
+677% +$521K ﹤0.01% 4551
2019
Q3
$74K Buy
1,854
+433
+30% +$16.7K ﹤0.01% 5951
2019
Q2
$60K Buy
1,421
+1,221
+611% +$54K ﹤0.01% 5757
2019
Q1
$9K Sell
200
-1,275
-86% -$58.4K ﹤0.01% 6873
2018
Q4
$66K Buy
1,475
+40
+3% +$1.73K ﹤0.01% 5872
2018
Q3
$68K Buy
1,435
+259
+22% +$11.3K ﹤0.01% 5919
2018
Q2
$47K Sell
1,176
-780
-40% -$33.2K ﹤0.01% 6009
2018
Q1
$80K Buy
1,956
+1,286
+192% +$47.7K ﹤0.01% 5376
2017
Q4
$22K Sell
670
-5,502
-89% -$151K ﹤0.01% 6476
2017
Q3
$164K Buy
6,172
+5,776
+1,459% +$163K ﹤0.01% 4983
2017
Q2
$13K Buy
396
+16
+4% +$714 ﹤0.01% 6600
2017
Q1
$21K Sell
380
-1,626
-81% -$96.9K ﹤0.01% 6102
2016
Q4
$125K Buy
2,006
+1,512
+306% +$92.3K ﹤0.01% 5133
2016
Q3
$27K Sell
494
-2,065
-81% -$130K ﹤0.01% 6030
2016
Q2
$165K Sell
2,559
-1,417
-36% -$93.7K ﹤0.01% 4668
2016
Q1
$287K Buy
3,976
+517
+15% +$33.4K ﹤0.01% 4216
2015
Q4
$197K Buy
3,459
+1,537
+80% +$88.9K ﹤0.01% 4679
2015
Q3
$110K Buy
1,922
+486
+34% +$30.2K ﹤0.01% 5150
2015
Q2
$94K Buy
1,436
+266
+23% +$18.3K ﹤0.01% 5450
2015
Q1
$83K Buy
1,170
+834
+248% +$60.5K ﹤0.01% 5573
2014
Q4
$25K Buy
+336
New +$25.5K ﹤0.01% 7315

Other funds holding GCO

UBS Group's GCO Position: Q2 2026 in Review

UBS Group reduced its Genesco (GCO) stake by 38% in Q2 2026, selling an estimated $1.76M and leaving 82,426 shares worth $2.78M. The position accounts for ﹤0.01% of the portfolio, ranked #4781.

UBS Group first reported a position in GCO in Q4 2014 and has held it in 47 quarters since. The position peaked at $8.28M in Q4 2024. 142 funds tracked by Wall St. Rank hold GCO as of Q2 2026.

  • UBS Group held 82,426 shares of Genesco worth $2.78M as of Q2 2026.
  • UBS Group sold 50,213 Genesco shares in Q2 2026, an estimated $1.76M.
  • Genesco made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #4781 holding.
  • UBS Group first reported a position in Genesco in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's Genesco position peaked at $8.28M in Q4 2024.
  • 142 funds tracked by Wall St. Rank held Genesco as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.